Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides

碩士 === 中原大學 === 化學研究所 === 105 === This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy. In addition, the synthesis of the sphingosine derivative xyl-13 will b...

Full description

Bibliographic Details
Main Authors: Jain-Ming Chen, 陳建銘
Other Authors: Yow-Fu Tsai
Format: Others
Language:zh-TW
Published: 2017
Online Access:http://ndltd.ncl.edu.tw/handle/64994835480195387779
id ndltd-TW-105CYCU5065040
record_format oai_dc
spelling ndltd-TW-105CYCU50650402017-09-22T04:33:53Z http://ndltd.ncl.edu.tw/handle/64994835480195387779 Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides 治療神經退化疾病之藥物的開發研究:神經鞘胺醇的製備與唾液酸醣苷神經鞘醯胺Neu5GcHp-s1及其具多樣性神經鞘醯胺之類似物合成 Jain-Ming Chen 陳建銘 碩士 中原大學 化學研究所 105 This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy. In addition, the synthesis of the sphingosine derivative xyl-13 will be carried out to synthesize the ceramide. The synthesis of Hp-SJG1, Hp-SJG2 and Hp-SJG3 main architectures NGLA-1, NGLR-1 and NGLM-1 has been completed. Yow-Fu Tsai 蔡祐輔 2017 學位論文 ; thesis 187 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 中原大學 === 化學研究所 === 105 === This paper aims to complete neurodegenerative activity of ganglioside Hp-s1 analogues Hp-SJ1、Hp-SJ2、Hp-SJ3 synthesis, we used chemoselective glycosylation reaction and [1+1+2] synthetic strategy. In addition, the synthesis of the sphingosine derivative xyl-13 will be carried out to synthesize the ceramide. The synthesis of Hp-SJG1, Hp-SJG2 and Hp-SJG3 main architectures NGLA-1, NGLR-1 and NGLM-1 has been completed.
author2 Yow-Fu Tsai
author_facet Yow-Fu Tsai
Jain-Ming Chen
陳建銘
author Jain-Ming Chen
陳建銘
spellingShingle Jain-Ming Chen
陳建銘
Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
author_sort Jain-Ming Chen
title Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
title_short Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
title_full Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
title_fullStr Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
title_full_unstemmed Studies on the Development of Medicines for Fighting Neurodegenerative Diseases: Synthesis of sphingosine and Ganglioside Neu5GcHp-s1 and it’s Analogues with Various Ceramides
title_sort studies on the development of medicines for fighting neurodegenerative diseases: synthesis of sphingosine and ganglioside neu5gchp-s1 and it’s analogues with various ceramides
publishDate 2017
url http://ndltd.ncl.edu.tw/handle/64994835480195387779
work_keys_str_mv AT jainmingchen studiesonthedevelopmentofmedicinesforfightingneurodegenerativediseasessynthesisofsphingosineandgangliosideneu5gchps1anditsanalogueswithvariousceramides
AT chénjiànmíng studiesonthedevelopmentofmedicinesforfightingneurodegenerativediseasessynthesisofsphingosineandgangliosideneu5gchps1anditsanalogueswithvariousceramides
AT jainmingchen zhìliáoshénjīngtuìhuàjíbìngzhīyàowùdekāifāyánjiūshénjīngqiàoànchúndezhìbèiyǔtuòyèsuāntánggānshénjīngqiàoxīànneu5gchps1jíqíjùduōyàngxìngshénjīngqiàoxīànzhīlèishìwùhéchéng
AT chénjiànmíng zhìliáoshénjīngtuìhuàjíbìngzhīyàowùdekāifāyánjiūshénjīngqiàoànchúndezhìbèiyǔtuòyèsuāntánggānshénjīngqiàoxīànneu5gchps1jíqíjùduōyàngxìngshénjīngqiàoxīànzhīlèishìwùhéchéng
_version_ 1718539541644574720